🔴 Pyxis Oncology is trading 5.18% down today after MICVO response rate fell to 36%

Pyxis Oncology is trading 5.18% down at $3.21 after updated Phase 1 MICVO data showed a 36% confirmed response rate among 33 evaluable patients.

• The confirmed response rate compares with 46% previously reported, while disease control remained 94%.
• Investors appear concerned about the weaker response signal.
• Broader markets are also lower amid hotter producer inflation and elevated oil prices.